🏠New concept: Hepatology@Home Delivering expert care to complex patients in the community: Ascitic taps, LVP, antibiotics, diuretics. ✅Feasible ✅Safe ✅Avoids admission It's been v inspiring to watch @TamCarg grow this service from nothing👏 @ebtapper @serperm @NnekaUfereMD

Thank you for accepting our invitation sir. It was lovely to have you all here. Look forward to meeting you at @AASLDtweets TLM @VCU_Liver @ArunJSanyalVCU @gvraoaig

Wrapping one week of hosting the 🐐 Dr. Anna Lok in Seattle for her sabbatical. ❤️her🌟🌟lessons on how to: 1️⃣ Have a long & meaningful career in academics. 2️⃣ How to treat and ?maybe, one day, functionally cure HBV 🦠

The @DeptVetAffairs has been recognized for its innovative contributions, ranking 17th among the top 60 non-profit research institutions and government agencies worldwide for U.S. utility patents granted in 2024 by the National @AcadofInventors (NAI). https://t.co/NJJFONQQ88

Proud to share our new global MASLD/MASH consensus in @AGA_Gastro. This was an international effort by experts in hepatology, endocrinology, primary care, and patient advocacy. The article provides unified, practical guidance for diagnosis, risk stratification, and treatment,

#FDA: Liver Stiffness Measurement #LSM =accepted surrogate endpoint in MASLD #MASH🔗 https://t.co/PjlA1eFxY8 LSM predicts liver-related events #LRE =LBX Regression to LSM<10kPa -75% risk Progression to LSM≥10kPa +400% risk @BavenoCoop Rule-of-5⃣ in cACLD ±20% LSM 🔀 ±50% risk

Cardiovascular-kidney-metabolic #CKM syndrome links obesity, diabetes, CKD & CVD in a continuum. New review: SGLT2i & GLP-1RA have powerful heart, kidney & metabolic protection across diverse patient populations. https://t.co/alwVEob6QJ

MetALD associated with a higher risk of liver-related events, HCC, and extrahepatic cancers than MASLD, whereas all-cause mortality, extrahepatic cancer-related mortality, and cardiovascular events seem similar between the two conditions. https://t.co/PCdUyXbnub

Insightful commentary in @Nature about rapid weight loss with GLP-1 meds which can lead to significant muscle loss or even #sarcopenia. Muscle-preserving strategies, exercise, adequate protein (~1.2-1.6 g/kg/d), creatine, and promising new agents like #bimagrumab and myostatin

Truly privileged to be here #AnnArbor in person on behalf of @CUHKMedicine @CUHKGI to celebrate with the big Lok's Family at @UMichMedSchool @MichiganLiver #BestMentorEver 🥰🥰👩🏻‍🏫👩🏻‍🏫#BestAcademicGrandMaEver 😄😄👵🏻👵🏻

⭐ This team developed a new model for predicting liver cancer risk in Alaska Natives. The model uses 11 predictors, including HBV genotype and AFP, and can accurately estimate liver cancer risk during follow-up. 👨‍⚕️ @gnioannou @nje_kim @TrangVoPham 🔗 https://t.co/GMqfTbCfFS

Intercept Announces Voluntary Withdrawal of OCALIVA® for Primary Biliary Cholangitis (PBC) from the US Market; US Clinical Trials Involving Obeticholic Acid Placed on Clinical Hold

👏 Congratulations to Pedro Ochoa-Allemant of the University of Pennsylvania for receiving the 2025 #AASLDFoundation Anna S. Lok Advanced/Transplant #Hepatology Fellow Award!

This is one of my favorite studies. Regardless of liver disease severity or degree of portal hypertension: 🛑 alcohol ⬇️ decompensation AND ⬆️ survival ‼️Critical info for ALD: It is never too late to stop drinking🍸! @BenediktHofer @ReibergerThomas https://t.co/2Yo5ji67j7

🆕@AmCollegeGastro Guideline: ➡ Perioperative Risk Assessment & Management in Cirrhosis How to: 1️⃣Assess & Optimize for surgery cirrhosis patients with low risk 2️⃣Avoid surgery in those with high risk https://t.co/YQGm7C2PMp

🚨 New @AmJGastro ACG Guideline 🚨 Pre-op risk assessment in chronic liver disease ▪️Assess for CSPH ▪️Use MELD & VOCALPenn for surgical risk ▪️Screen for HCC & EV ▪️>15% 90d mortality → consider LT eval ▪️TIPS in select high-risk cases 🔗 https://t.co/p5JViI35vt

✨ Ακόμη ένα μεγάλο βήμα μπροστά για τον οργανισμό μας! Υπογράψαμε τα συμβόλαια για το νέο μας κτήριο φυσιοθεραπείας. Με σύγχρονες εγκαταστάσεις και βελτιωμένες υπηρεσίες συνεχίζουμε να αναβαθμίζουμε τη φροντίδα προς τους ασθενείς μας. ✨

Community screening for cirrhosis by FibroScan in 🇬🇧 with further screening for liver cancer❗️ Thousands referred for liver cancer checks after on-the-spot scan

🚨 AI won’t replace doctors… but it can prevent them from learning how to think. A critical article in @NEJM shows that if introduced too early in medical training, it weakens clinical reasoning. ✅ A good doctor will always need critical thinking. N Engl J Med 2025;393:786

Congratulations to two outstanding leaders in liver and research on their endowed professorships - Neehar Parikh and @ebtapper - especially grateful to be included in the ceremony for our amazing friend @laurakulik1 @docamitgs @serperm @MichiganLiver